Compare, Analyse Cadila Healthcare with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs ADCOCK INGRAM (S. Africa) - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 CADILA HEALTHCARE   ADCOCK INGRAM
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-18
ADCOCK INGRAM
Jun-14
CADILA HEALTHCARE/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs558347-   
Low Rs362251-   
Sales per share (Unadj.) Rs116.3103.3-  
Earnings per share (Unadj.) Rs17.9-26.0-  
Cash flow per share (Unadj.) Rs23.1-21.6-  
Dividends per share (Unadj.) Rs3.500-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs85.481.1-  
Shares outstanding (eoy) m1,023.74168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.02.9 136.6%   
Avg P/E ratio x25.7-11.5 -224.1%  
P/CF ratio (eoy) x19.9-13.9 -143.4%  
Price / Book Value ratio x5.43.7 146.0%  
Dividend payout %19.60-   
Avg Mkt Cap Rs m470,66450,448 933.0%   
No. of employees `00011.84.3 275.3%   
Total wages/salary Rs m18,5453,166 585.7%   
Avg. sales/employee Rs Th10,072.74,061.4 248.0%   
Avg. wages/employee Rs Th1,569.1737.5 212.8%   
Avg. net profit/employee Rs Th1,547.7-1,023.4 -151.2%   
INCOME DATA
Net Sales Rs m119,04917,436 682.8%  
Other income Rs m1,132122 927.1%   
Total revenues Rs m120,18117,558 684.5%   
Gross profit Rs m28,475-3,021 -942.4%  
Depreciation Rs m5,388753 716.0%   
Interest Rs m911472 192.9%   
Profit before tax Rs m23,308-4,124 -565.2%   
Minority Interest Rs m628-11 -5,462.8%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,644258 2,190.1%   
Profit after tax Rs m18,292-4,393 -416.4%  
Gross profit margin %23.9-17.3 -138.0%  
Effective tax rate %24.2-6.2 -387.5%   
Net profit margin %15.4-25.2 -61.0%  
BALANCE SHEET DATA
Current assets Rs m82,00512,770 642.2%   
Current liabilities Rs m60,7207,185 845.1%   
Net working cap to sales %17.932.0 55.8%  
Current ratio x1.41.8 76.0%  
Inventory Days Days73111 65.9%  
Debtors Days Days98124 79.3%  
Net fixed assets Rs m83,7037,444 1,124.5%   
Share capital Rs m1,02481 1,265.0%   
"Free" reserves Rs m86,4210-   
Net worth Rs m87,44513,685 639.0%   
Long term debt Rs m25,5514,809 531.3%   
Total assets Rs m180,65325,852 698.8%  
Interest coverage x26.6-7.7 -343.8%   
Debt to equity ratio x0.30.4 83.1%  
Sales to assets ratio x0.70.7 97.7%   
Return on assets %10.6-15.2 -70.1%  
Return on equity %20.9-32.1 -65.2%  
Return on capital %22.0-19.8 -111.0%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m31,4410-   
CASH FLOW
From Operations Rs m9,1931,488 617.7%  
From Investments Rs m-9,737-457 2,130.8%  
From Financial Activity Rs m5154,365 11.8%  
Net Cashflow Rs m-295,396 -0.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.79 Rs / ZAR

Compare CADILA HEALTHCARE With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare CADILA HEALTHCARE With: PIRAMAL ENTERPRISES  GLENMARK PHARMA  CIPLA  JUBILANT LIFE SCIENCES  STRIDES PHARMA SCIENCE  



Today's Market

Sensex Ends above 39,000-Mark; Automobile and Banking Stocks Witness Buying(Closing)

Extending gains to the fifth day, Indian share markets rose sharply during the afternoon session and ended on a strong note.

Related Views On News

CADILA HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 28.9% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CADILA HEALTHCARE has posted a net profit of Rs 3 bn (down 28.9% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 21.0% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 21.0% YoY). Sales on the other hand came in at Rs 37 bn (up 14.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of CADILA HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

Rebound Riches Could be Yours With These Stocks (Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Oct 17, 2019 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 5-YR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS